Okla. Stat. tit. 43A § 2-401.1

Current through Laws 2024, c. 453.

Section 2-401.1

A. As used in this section, "emergency opioid antagonist" means a drug including but not limited to naloxone that blocks the effects of opioids and that is approved by the United States Food and Drug Administration for the treatment of an opioid overdose.

B. Subject to allocation of federal funding for the purchase of emergency opioid antagonists, the Department of Mental Health and Substance Abuse Services shall provide emergency opioid antagonists to the Department of Corrections and to county jails for the purpose of implementing Section 2 of this act.

C. The Department of Mental Health and Substance Abuse Services shall prepare and provide an opioid overdose education program to the Department of Corrections and to county jails for the purpose of implementing Section 2 of this act. The education program shall:

1. Conform to guidelines of the Substance Abuse and Mental Health Services Administration for opioid overdose education;

2. Explain the causes of an opioid overdose;

3. Instruct when and how to administer in accordance with medical best practices:

a. life-saving rescue techniques, and

b. an emergency opioid antagonist;

4. Explain how to contact appropriate emergency medical services; and

5. Provide information on how to access emergency opioid antagonists.

Okla. Stat. tit. 43A, § 2-401.1

Added by Laws 2023 , c. 311, s. 1, eff. 11/1/2023.